Carlsmed Inc (CARL)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Carlsmed Inc Stock (CARL) Company Profile

Carlsmed Inc

Healthcare (1157)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CARL's Discussions on Twitter

Vergleichen Sie CARL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CARL Carlsmed Inc	13.04	349.48M	0	0	0	0.00
VEEV Veeva Systems Inc	290.86	46.10B	2.86B	780.66M	1.19B	4.72
TEM Tempus Ai Inc	80.52	13.63B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	67.74	12.35B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	89.82	7.74B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	36.24	6.32B	906.14M	-52.62M	89.62M	-0.3621

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-18	Eingeleitet	BTIG Research	Buy
2025-08-18	Eingeleitet	BofA Securities	Buy
2025-08-18	Eingeleitet	Goldman	Buy
2025-08-18	Eingeleitet	Piper Sandler	Overweight
2025-08-18	Eingeleitet	Truist	Buy

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Es liegen keine Finanzdaten für Carlsmed Inc (CARL) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Carlsmed Inc-Aktie (CARL) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Sidow Kevin	Director	Jul 24 '25	Buy	15.00	13,333	199,995	59,566
Mittendorff Robert II	Director	Jul 24 '25	Buy	15.00	1,333,333	19,999,995	5,013,839
ROOT JONATHAN D	Director	Jul 24 '25	Buy	15.00	466,666	6,999,990	483,999
YOUNG PHILIP M	Director	Jul 24 '25	Buy	15.00	59,999	899,985	53,333

Carlsmed Inc (CARL)

Carlsmed Inc Stock (CARL) Company Profile

Vergleichen Sie CARL mit anderen Aktien

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Carlsmed initiated with Buy at Truist on business potential - MSN

Why Is Carlsmed Stock Gaining Monday?Carlsmed (NASDAQ:CARL) - Benzinga

AI medtech firm Carlsmed prices $100.5M IPO - MSN

Carlsmed initiated with Buy at Truist on business potential (CARL) - Seeking Alpha

BofA Securities Initiates Coverage on Carlsmed With Buy Rating, $16 Price Target - MarketScreener

This Synaptics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Goldman Sachs Initiates Coverage on Carlsmed With Buy Rating, $19 Price Target - MarketScreener

Truist Securities initiates coverage on Carlsmed stock with Buy rating - Investing.com

Truist Initiates Carlsmed at Buy With $18 Price Target - MarketScreener

Piper Sandler initiates coverage on Carlsmed with an Overweight rating, PT of $18. - AInvest

Carlsmed stock initiated with Buy rating at BTIG on customized implant tech - Investing.com

Carlsmed stock initiated with Buy rating at BTIG on customized implant tech By Investing.com - Investing.com South Africa

Piper Sandler initiates Carlsmed stock with Overweight rating on custom implant potential - Investing.com India

Goldman Sachs initiates coverage on Carlsmed stock with Buy rating - Investing.com

Goldman Sachs initiates coverage on Carlsmed stock with Buy rating By Investing.com - Investing.com Nigeria

Carlsmed initiated with a Buy at Goldman Sachs - MSN

AI medtech firm Carlsmed to sell 6.7M shares in IPO - MSN

Carlsmed, Inc. shares fall 2.01% after-hours as it prepares to report Q2 2025 financial results. - AInvest

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - The Manila Times

Carlsmed to report Q2 2025 financial results on Aug 28, 2025. - AInvest

Big Boost for Personalized Cervical Fusion: Add-On Code - Orthopedics This Week

Heartflow raises $317M, pops 66% at market open - BioWorld MedTech

Carlsmed’s $100.5M IPO fuels 3D printed spinal implants growth - 3D Printing Industry

Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures - TipRanks

Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Ortho Spine News

Carlsmed's Aprevo Implants Receive CMS NTAP Approval For Cervical Fusion Procedures Under FY2026 IPPS Final Rule - 富途牛牛

Carlsmed's Aprevo Personalized Interbody Implants Receive CMS NTAP for Cervical Fusion Procedures - AInvest

US Life Sciences IPOs Revive with Medtech Companies Leading the Way - AInvest

Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - Bloomberg.com

Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery - MarketScreener

Carlsmed announces completion of first aprevo cervical procedure - TipRanks

Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery - Ortho Spine News

Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery. - AInvest

Carlsmed’s Nasdaq Debut Gets $100.5M - San Diego Business Journal

Carlsmed Launches $100.5 Million Initial Public Offering - Global Legal Chronicle

Carlsbad-based medical technology company begins trading on Nasdaq - MSN

Latham & Watkins Advises on Carlsmed, Inc.’s US$100.5 Million Initial Public Offering - Latham & Watkins LLP

Carlsmed Insider Bought Shares Worth $899,985, According to a Recent SEC Filing - MarketScreener

Carlsmed director Philip Young buys $900k in shares By Investing.com - Investing.com South Africa

Carlsmed (CARL) director Sidow buys $199,995 in shares By Investing.com - Investing.com India

Carlsmed (CARL) director Sidow buys $199,995 in shares - Investing.com Australia

Carlsmed director Philip Young buys $900k in shares - Investing.com

Carlsmed director Mittendorff buys $20 million in shares By Investing.com - Investing.com India

Carlsmed director Mittendorff buys $20 million in shares - Investing.com

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Carlsmed Inc-Aktie (CARL) Insiderhandel

Ähnlich wie CARL